CRME

Cardiome Pharma Corp.

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Correvio Pharma Corp. market cap is $167.03M.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Correvio Pharma Corp. 52 week high is $5.24 as of November 13, 2025.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Correvio Pharma Corp. 52 week low is $1.29 as of November 13, 2025.

Correvio Pharma Corp. stock price today is $4.75.

Correvio Pharma Corp. stock price yesterday was $4.79.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Correvio Pharma Corp.’s P/E ratio is None.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Correvio Pharma Corp. P/B ratio is 11.3159.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Correvio Pharma Corp.'s EBITDA is -6.02.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Correvio Pharma Corp. 50-day moving average is $4.47.

Correvio Pharma Corp. has 163 employees.